Oxurion Announces the Continuation of KALAHARI Phase 2, Part

Oxurion Announces the Continuation of KALAHARI Phase 2, Part B Study in Diabetic Macular Edema Following Interim Analysis

Oxurion Announces the Continuation of KALAHARI Phase 2, Part B Study in Diabetic Macular Edema Following Interim Analysis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Boston , Massachusetts , United States , Leuven , Region Flamande , Belgium , Tom Graney , Westwickechristopher Brinzeytel , Usconway Communicationsbeth Kurth , Oxurion Nvtom Graneychief , Company Annual , Data Monitoring Committee , Wall Street , Top Line Data Anticipated , Euronext Brussels , Independent Data Monitoring Committee , Andy De Deene , Chief Development Officer , Chief Executive Officer , Macular Edema , Optical Coherence Tomography , Central Subfield Thickness , Graneychief Executive Officertel , Dillenchief Business Officertel , Communicationsbeth Kurth , Christopher Brinzeytel ,